SSY GROUP (02005) has obtained the drug production registration certificate for Vitamin K1 injection (1ml: 10mg).

SSY GROUP (02005) announced that the group has obtained the drug production registration approval from the National Medical Products Administration of China for Vitamin K1 Injection (1ml:10mg), which is classified as a Class 3 chemical drug and is deemed to have passed the consistency evaluation. Vitamin K1 Injection is mainly used to treat vitamin K deficiency bleeding and to prevent vitamin K deficiency that cannot be addressed through nutritional supplementation. Vitamin K1 Injection is a fundamental clinical medication, widely used for bleeding prevention and emergency treatment, with a large market scale. The approval of this product enriches the group's portfolio of injectable products.